Новости

TABLE 1.

Treatment of Tuberculosis

SUMMARY Responsibility for Successful Treatment The overall goals for treatment of tuberculosis are (1) to cure the individual patient, and (2) to minimize the transmission of Mycobacterium tuberculosis to other persons. Thus, successful treatment of tuberculosis has benefits both for the individual patient and the community in which the patient resides. For this reason the / прочети повече

New guidelines for the management of adult lower respiratory tract infections

Guidelines for the management of adult lower respiratory tract infections (LRTIs) were first published by a Task Force of the European Respiratory Society (ERS) in 1998 [1]. In 2005, a completely revised version was produced, this time by a joint Task Force of the ERS and the European Society for Clinical Microbiology and Infectious Diseases / прочети повече

FIGURE 1. Mean pulmonary artery pressure (P¯pa) in a hospital-based cohort of 998 chronic obstructive pulmonary disease (COPD) patients with a mild to very severe airflow limitation.

Pulmonary hypertension in COPD

ABSTRACT: Mild-to-moderate pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD); such a complication is associated with increased risks of exacerbation and decreased survival. Pulmonary hypertension usually worsens during exercise, sleep and exacerbation. Pulmonary vascular remodelling in COPD is the main cause of increase in pulmonary artery pressure and is thought to / прочети повече

FIGURE 1. Definition of a morbidity/mortality event: primary end-point used in the SERAPHIN trial.

Looking to the future: a new decade of pulmonary arterial hypertension therapy

ABSTRACT: Pulmonary arterial hypertension (PAH) is a severe and debilitating disease characterised by vascular proliferation and remodelling of the small pulmonary arteries, leading to a progressive increase in pulmonary vascular resistance, increased afterload on the right ventricle and, ultimately, right heart failure. Although there is no ‘‘cure’’ for PAH, the availability of targeted therapies over / прочети повече

Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sectionsondefinitionandepidemiology, / прочети повече

Emphysema-A-Disease-of-Small-Airways-or-Lung-Parenchyma

Emphysema — A Disease of Small Airways or Lung Parenchyma?

In 1984, the Division of Lung Diseases at the National Heart, Lung, and Blood Institute funded a workshop that led to what is still the basis for most definitions of emphysema: “a condition of the lung characterized by abnormal, permanent enlargement of airspaces distal to the terminal bronchiole, accompanied by the destruction of their walls, / прочети повече

Table 1. Characteristics of the 78 Patients and Controls.*

Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease

Abstract Background The major sites of obstruction in chronic obstructive pulmonary disease (COPD) are small airways (<2 mm in diameter). We wanted to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. Methods We used multidetector computed tomography (CT) to compare the number of airways measuring 2.0 to 2.5 mm / прочети повече

Заболеваемост от туберкулоза в България.

Методическо указание за насочване, диагноза, проследяване и лечение на лицата с латентна туберколозна инфекция

Приложение към Заповед№РД 28-29 / 27.01.2011 г. 1.Епидемиология на туберкулозата Туберкулозата е една от най-древните болести, познати на човечеството. Въпреки постигнатите успехи в областта на инфекциозната патология през изминалото столетие, тя запазва своята значимост и все още представлява сериозно предизвикателство. Още през 1993 г. СЗО изрази тревогата си от тенденцията за нарастване на разпространението на / прочети повече

Фиг. 1. Нормална спирограма и спирограма, типична за пациенти с лека до умерена ХОББ*

Кратки препоръки за диагностика, лечение и превенция на ХОББ

Препоръките са изготвени от работна група на Българско дружество по белодробни болести (БДББ), в състав: доц. Коста Костов, доц. Денчо Османлиев, доц. Огнян Георгиев, доц. Явор Иванов, доц. Владимир Ходжев, доц. Димитър Попов, д-р. Димитър Граматиков, доц. М. Пенева Те се базират на следните консенсусни документи: Global Initiative for Chronic Obstructive Lung Disease. Global Strategy / прочети повече

Безопасност на дългодействащите β-агонисти при стабилна ХОББ: системен обзор

Safety of long-acting β-agonists in stable COPD   Автори: Gustavo Rodrigo, Luis Nannini, Roberto Rodriguez-Roisin Спешно отделение, Централна болница, Монтевидео, Уругвай; Неврологично отделение, Университетска болница Г. Баигориа, Санта Фе, Аржентина; Пулмологична клиника, Институт по биомедицински изследвания, Университет на Барселона, Барселона, Испания Публикация в Chest 2008; 133:1079-1087   Някои проучвания подсказват, че употребата на дългодействащи β2-агонисти / прочети повече